Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Linder

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Clinical Therapeutics|April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in GermanySebastian Braun, Leo Russo, Jan Zeidler, et al.
GMS Krankenhaushygiene Interdisziplinar|January 14, 2012
The project HICARE: cross-sectoral action alliance against multi-resistant pathogensRoland Linder, Isabell Thoms, Ingo Pfenning, et al.
The Journal of Investigative Dermatology|July 27, 2016
Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in GermanyFranziska Hübner, Andreas Recke, Detlef Zillikens, et al.
Deutsches Arzteblatt International|April 9, 2011
The benefit and efficiency of the disease management program for type 2 diabetesRoland Linder, Susanne Ahrens, Dagmar Köppel, et al.
Deutsches Arzteblatt International|November 25, 2011
Correspondence (reply): In ReplyRoland Linder, Susanne Ahrens, Frank Verheyen, et al.
Physiological Measurement|December 21, 2005
A computer-based approach to assess the perception of composite odour intensity: a step towards automated olfactometry calibrationMathias Wagner, Holger Sudhoff, Małgorzata Zamelczyk-Pajewska, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 8, 2019
Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance dataSebastian Klose, René Pflock, Inke R König, et al.
Applied Health Economics and Health Policy|July 25, 2018
The Choice of Transcatheter Aortic Valve Implementation (TAVI): Do Patient Co-morbidity and Hospital Ownership Type Matter?Udo Schneider, Andreas Schmid, Roland Linder, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 18, 2016
Erratum to: Treatment costs of attention deficit hyperactivity disorder in GermanySebastian Braun, Jan Zeidler, Roland Linder, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 25, 2015
[Stepwise Diagnostics, Federal Joint Committee Directive and Actual Care in the Case of Sleep-related Breathing Disorders - An Analysis Based on Claims Data of the Techniker Krankenkasse]Udo Schneider, Roland Linder, Ernst-Günther Hagenmeyer, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Clinical Therapeutics|April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in GermanySebastian Braun, Leo Russo, Jan Zeidler, et al.
GMS Krankenhaushygiene Interdisziplinar|January 14, 2012
The project HICARE: cross-sectoral action alliance against multi-resistant pathogensRoland Linder, Isabell Thoms, Ingo Pfenning, et al.
The Journal of Investigative Dermatology|July 27, 2016
Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in GermanyFranziska Hübner, Andreas Recke, Detlef Zillikens, et al.
Deutsches Arzteblatt International|April 9, 2011
The benefit and efficiency of the disease management program for type 2 diabetesRoland Linder, Susanne Ahrens, Dagmar Köppel, et al.
Deutsches Arzteblatt International|November 25, 2011
Correspondence (reply): In ReplyRoland Linder, Susanne Ahrens, Frank Verheyen, et al.
Physiological Measurement|December 21, 2005
A computer-based approach to assess the perception of composite odour intensity: a step towards automated olfactometry calibrationMathias Wagner, Holger Sudhoff, Małgorzata Zamelczyk-Pajewska, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 8, 2019
Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance dataSebastian Klose, René Pflock, Inke R König, et al.
Applied Health Economics and Health Policy|July 25, 2018
The Choice of Transcatheter Aortic Valve Implementation (TAVI): Do Patient Co-morbidity and Hospital Ownership Type Matter?Udo Schneider, Andreas Schmid, Roland Linder, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 18, 2016
Erratum to: Treatment costs of attention deficit hyperactivity disorder in GermanySebastian Braun, Jan Zeidler, Roland Linder, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 25, 2015
[Stepwise Diagnostics, Federal Joint Committee Directive and Actual Care in the Case of Sleep-related Breathing Disorders - An Analysis Based on Claims Data of the Techniker Krankenkasse]Udo Schneider, Roland Linder, Ernst-Günther Hagenmeyer, et al.
Pageof 8